Executive Summary

Oct 2019
PROSPECTS
Modern lifestyles and an ageing population underpin growth in dermatologicals

Dermatologicals saw steady growth over the review period in Hungary, with this being mainly driven by demographic and lifestyle trends. Increasing numbers of consumers are suffering from skin conditions, skin sensitivities, allergies, infections and eczema-related issues, in part due to modern lifestyles and chemicals.

Despite scepticism medicated shampoos and hair loss treatments see growth

Medicated shampoos has a relatively stable customer base with the increasing availability of such products helping it to record steady growth in the review period and in 2019. Scalp issues affect both men and women and as such medicated shampoos is seen as a promising area with a number of new brands being successfully launched during the review period, such as Bioderma, Eucerin and Revalid.

“Talking vaginas” help to raise awareness and break taboos

Given the nature of dermatologicals, there is some stigma and shame associated with using such products, or even talking about them. Since female consumers are more willing to open up, they are targeted by manufacturers with remarkable marketing campaigns for vaginal antifungals.

COMPETITIVE LANDSCAPE
‘Active Summer’ campaign drives interest in Bepanthen Plus as Bayer retains lead

Bayer Hungária maintained its lead in dermatologicals in 2018, thanks to the company’s flagship brand Canesten. Canesten is the leading brand in topical and vaginal antifungals, whilst its Bepanthen brand is ranked second in nappy (diaper) rash treatments.

Launch of Reparon Herbal helps raise profile of domestic company

Egis Gyógyszergyár was ranked second in dermatologicals in 2019, primarily due to the enduring popularity of its traditional and trusted brands Reparon and Betadine. Betadine led topical germicidals/antiseptics in 2019, with the product now also available in hypermarkets and drugstores/parapharmacies.

Trusted products and advertising benefits Teva Gyógyszergyár

Teva Gyógyszergyár Zrt ended its joint venture with Procter & Gamble in 2018, with it sitting in fourth place in the rankings in 2019. The company’s flagship brands include Neogranormon and Sudocrem which are leading brands in nappy (diaper) rash treatments.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Dermatologicals in Hungary

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Hungary with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Hungary, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Hungary market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in Hungary?
  • What are the major brands in Hungary?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Dermatologicals in Hungary - Category analysis

HEADLINES

PROSPECTS

Modern lifestyles and an ageing population underpin growth in dermatologicals
Despite scepticism medicated shampoos and hair loss treatments see growth
“Talking vaginas” help to raise awareness and break taboos

COMPETITIVE LANDSCAPE

‘Active Summer’ campaign drives interest in Bepanthen Plus as Bayer retains lead
Launch of Reparon Herbal helps raise profile of domestic company
Trusted products and advertising benefits Teva Gyógyszergyár

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2014-2019
Table 2 Sales of Dermatologicals by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Dermatologicals: % Value 2015-2019
Table 4 LBN Brand Shares of Dermatologicals: % Value 2016-2019
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2016-2019
Table 6 Forecast Sales of Dermatologicals by Category: Value 2019-2024
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2019-2024

Consumer Health in Hungary - Industry Overview

EXECUTIVE SUMMARY

Consumer health sees strong growth thanks to lifestyle and demographic factors
Government launches “Programme for a more competitive Hungary”
Global giants lead but local players hold strong presence thanks to investment
Chemists/pharmacists remains king, but internet retailing offers potential
The signs point towards a bright future for consumer health although challenges remain

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 9 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2014-2019
Table 11 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 12 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 13 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format: % Value 2014-2019
Table 16 Distribution of Consumer Health by Format and Category: % Value 2019
Table 17 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources